Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Zhi Guo
Institutions:
Shenzhen University,
Wuhan University of Science and Technology
Observed institutions:
Shenzhen University,
Shenzhen University Health Science Center,
Wuhan University of Science and Technology,
Huazhong University of Science and Technology
ORCID:
0009-0005-8029-2457
Observed ORCID:
0009-0005-8029-2457
OpenAlex ID:
A5040321649
Split-design approach enhances the therapeutic efficacy of ligand-based CAR-T cells against multiple B-cell malignancies
2024
·
Shuhong Li
, Licai Shi
, et al.
·
Nature Communications
·
17
Prognostic value of tumor-infiltrating lymphocyte subtypes and microorganisms in triple-negative breast cancer
2024
·
Yating Shi
, Zhi Guo
, et al.
·
Journal of Cancer Research and Therapeutics
·
14
The first case of multiple myeloma treated with ASCT followed by Anti-BCMA CAR-T cells using retrovirus vector: A case report
2024
·
Liqiong Liu
, Wenxiang Zhu
, et al.
·
Heliyon
·
4
Upfront autologous hematopoietic stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma: A real-world multicenter study
2025
·
Zhi Guo
, Xiaomin Xian
, et al.
·
Journal of Cancer Research and Therapeutics
·
2
Editorial: Innovative approaches to combat tumorigenesis and drug resistance: from molecular insights to therapeutic advancements
2026
·
Zhi Guo
·
Frontiers in Cell and Developmental Biology
PDF
Show more works
View as search
Works count:
5
Citation count:
37
H-index:
3
I10-index:
2
Year
Topic
Type